BI 894416 clinical trials
Also written BI 894416.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses BI 894416 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- BI 894416
- 6
Studies by the year they started
7 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses BI 894416 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Study in Healthy Men to Find the Best Formulation of BI 894416 and to Test How This is Taken up in the BodyTerminatedPhase 1Boehringer IngelheimNCT04232839Written as BI 894416 Reference Formulation
- This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is ToleratedCompletedPhase 1Boehringer IngelheimNCT03315936Written as BI 894416
- Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild AsthmaCompletedPhase 1Boehringer IngelheimNCT03971539Written as BI 894416
- A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are ToleratedTerminatedPhase 1Boehringer IngelheimNCT04540874Written as BI 894416
- A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 894416 in the BloodCompletedPhase 1Boehringer IngelheimNCT03722173Written as BI 894416
- A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 894416 in the BloodCompletedPhase 1Boehringer IngelheimNCT04060719Written as BI 894416
- A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the BloodCompletedPhase 1Boehringer IngelheimNCT03871595Written as BI 894416